Total Payments
$2,799
2024 Payments
$714.99
Companies
26
Transactions
166
Medicare Patients
1,752
Medicare Billing
$189,780
Payment Breakdown by Category
Food & Beverage$2,799 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,799 | 166 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $825.25 | 57 | $0 (2024) |
| Novo Nordisk Inc | $242.46 | 15 | $0 (2024) |
| Lilly USA, LLC | $219.43 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $208.64 | 6 | $0 (2023) |
| Daiichi Sankyo Inc. | $173.70 | 8 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $166.06 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $132.84 | 10 | $0 (2024) |
| PFIZER INC. | $110.88 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $100.11 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $94.77 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $714.99 | 40 | Amgen Inc. ($331.26) |
| 2023 | $221.01 | 13 | Lilly USA, LLC ($52.94) |
| 2022 | $297.63 | 18 | Novo Nordisk Inc ($67.80) |
| 2021 | $486.64 | 35 | Amgen Inc. ($124.13) |
| 2020 | $328.16 | 22 | Amgen Inc. ($131.96) |
| 2019 | $200.74 | 14 | Amgen Inc. ($86.75) |
| 2018 | $216.13 | 7 | GlaxoSmithKline, LLC. ($125.00) |
| 2017 | $333.44 | 17 | Daiichi Sankyo Inc. ($161.87) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Bone Health | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Insomnia | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $22.60 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Biological | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $49.33 | General |
| Category: Sleep Apnea testing | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $40.96 | General |
| Category: Bone Health | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Bone Health | ||||||
| 08/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Inflammation | ||||||
| 06/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 482 | 933 | $104,491 | $60,993 |
| 2022 | 14 | 490 | 866 | $91,285 | $47,990 |
| 2021 | 9 | 419 | 734 | $80,960 | $44,155 |
| 2020 | 7 | 361 | 687 | $76,290 | $36,642 |
Total Patients
1,752
Total Services
3,220
Medicare Billing
$189,780
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 418 | $62,700 | $34,041 | 54.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 44 | 44 | $15,400 | $12,164 | 79.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 94 | 94 | $10,905 | $7,050 | 64.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 93 | 93 | $3,246 | $2,667 | 82.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 31 | $3,720 | $1,954 | 52.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 183 | $6,588 | $1,693 | 25.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 42 | 42 | $1,512 | $1,189 | 78.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 28 | $420.00 | $235.20 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 360 | $54,000 | $28,580 | 52.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 75 | 75 | $8,700 | $5,269 | 60.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 21 | $3,990 | $2,188 | 54.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $2,975 | $2,113 | 71.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 74 | 74 | $2,442 | $2,022 | 82.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 44 | 49 | $3,675 | $2,005 | 54.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 146 | $5,256 | $1,340 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 20 | $2,400 | $1,199 | 49.9% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 13 | 13 | $2,925 | $1,167 | 39.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 31 | $2,480 | $1,005 | 40.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $720.00 | $523.28 | 72.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 13 | 13 | $702.00 | $237.12 | 33.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 15 | 15 | $600.00 | $233.89 | 39.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 12 | $420.00 | $108.70 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 122 | 367 | $55,050 | $30,923 | 56.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 92 | 92 | $10,672 | $6,112 | 57.3% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 37 | 46 | $3,450 | $2,081 | 60.3% |
About Dr. Richard Michael, MD
Dr. Richard Michael, MD is a Pediatrics healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861496671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Michael, MD has received a total of $2,799 in payments from pharmaceutical and medical device companies, with $714.99 received in 2024. These payments were reported across 166 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,799).
As a Medicare-enrolled provider, Michael has provided services to 1,752 Medicare beneficiaries, totaling 3,220 services with total Medicare billing of $189,780. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Shreveport, LA
- Active Since 06/09/2005
- Last Updated 01/14/2019
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861496671
Products in Payments
- Otezla (Drug) $282.46
- Aimovig (Biological) $269.27
- SHINGRIX (Biological) $186.97
- EVENITY (Biological) $178.53
- Ozempic (Drug) $148.34
- JARDIANCE (Drug) $143.88
- INJECTAFER (Drug) $136.84
- MYRBETRIQ (Drug) $116.02
- MOUNJARO (Drug) $108.96
- Prolia (Biological) $94.99
- FARXIGA (Drug) $80.59
- TRULICITY (Drug) $75.09
- UBRELVY (Drug) $73.22
- LEQVIO (Drug) $72.08
- REXULTI (Drug) $66.01
- XIFAXAN (Drug) $50.81
- WatchPATONE (Device) $49.33
- Rybelsus (Drug) $46.78
- IBSRELA (Drug) $46.56
- Movantik (Drug) $36.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Shreveport
Patricia Pichilingue Reto, Md, MD
Pediatrics — Payments: $9,846
Pediatrics $9,846
Dr. Brondwyn Holliway, M.d, M.D
Pediatrics — Payments: $5,345
Pediatrics $5,345
Ms. Kendra Landry, Pa-C, PA-C
Pediatrics — Payments: $4,673
Pediatrics $4,673
Dr. Neslihan Gungor, M.d, M.D
Pediatrics — Payments: $3,852
Pediatrics $3,852
Margaret Crittell, Md, MD
Pediatrics — Payments: $3,405
Pediatrics $3,405
Donald Mack, Md, MD
Pediatrics — Payments: $3,395
Pediatrics $3,395